Telomir Pharmaceuticals, Inc. Common Stock • TELO

Capital at risk.

About Telomir Pharmaceuticals, Inc. Common Stock
Ticker
info
TELO
Trading on
info
NASDAQ
ISIN
info
US87975F1049
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Erez Aminov
Headquarters
info
100 SE 2nd Street, Miami, FL, United States, 33131
Employees
info
0
Website
info
https://telomirpharma.com
Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on reversing biological aging and degenerative diseases. It is developing Telomir-1, an oral small molecule metal ion regulator designed to protect against age-related conditions, including Progeria, Wilson's disease, and age-related macular degeneration (amd), as well as type 2 diabetes, cancer, and Alzheimer's disease. The company was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharmaceuticals, Inc. in October 2022. Telomir Pharmaceuticals, Inc. was incorporated in 2021 and is headquartered in Miami, Florida.
Metrics
BasicAdvanced
Market cap
info
$45.4M
P/E ratio
info
-
EPS
info
-$0.37
Dividend Yield
info
0.00%
Beta
info
-
Forward P/E ratio
info
0
EBIDTA
info
-
Ex dividend date
info
-
Price & volume
Market cap
info
$45.4M
Average daily volume
info
0.6M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
0
Price to book
info
6.5
Earnings
EPS
info
-$0.37
EPS estimate (current quarter)
info
-$0.07
EPS estimate (next quarter)
info
-$0.07
EBITDA
info
-
Revenues (TTM)
info
$0M
Revenues per share (TTM)
info
$0.00
Technicals
Beta
info
-
52-week High
info
$7.08
52-week Low
info
$1.12
50-day moving average
info
$1.46
200-day moving average
info
$2.15
Short ratio
info
2
Short %
info
10.05%
Management effectiveness
ROE (TTM)
info
-303.19%
ROA (TTM)
info
-167.42%
Profit margin
info
0.00%
Gross profit margin
info
$0M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
0.00%
Share stats
Outstanding Shares
info
34.4M
Float
info
18.7M
Insiders %
info
44.98%
Institutions %
info
6.91%
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.10
-$0.05
-100.00%
Q4 • 24Missed
-$0.07
-$0.10
30.00%
Q1 • 25Beat
-$0.17
-$0.08
-112.50%
Q2 • 25Missed
-$0.03
-$0.07
57.14%
Q3 • 25Beat
-
-
-
Q4 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$-5.1M
-∞%
Q2 • 25
$0M
$-1.1M
-∞%
Q3 • 25
NaN%
-78.26%
NaN%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$0.8M
$0.3M
41.99%
Q2 • 25
$7.4M
$0.4M
5.71%
Q3 • 25
792.24%
21.36%
-86.40%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-0.7M
-
$1M
$-0.7M
Q2 • 25
$-0.9M
-
$7.5M
$-0.9M
Q3 • 25
33.14%
-
616.02%
33.14%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Telomir Pharmaceuticals, Inc. Common Stock share?
Collapse

Telomir Pharmaceuticals, Inc. Common Stock shares are currently traded for undefined per share.

How many shares does Telomir Pharmaceuticals, Inc. Common Stock have?
Collapse

Telomir Pharmaceuticals, Inc. Common Stock currently has 34.4M shares.

Does Telomir Pharmaceuticals, Inc. Common Stock pay dividends?
Collapse

No, Telomir Pharmaceuticals, Inc. Common Stock doesn't pay dividends.

What is Telomir Pharmaceuticals, Inc. Common Stock 52 week high?
Collapse

Telomir Pharmaceuticals, Inc. Common Stock 52 week high is $7.08.

What is Telomir Pharmaceuticals, Inc. Common Stock 52 week low?
Collapse

Telomir Pharmaceuticals, Inc. Common Stock 52 week low is $1.12.

What is the 200-day moving average of Telomir Pharmaceuticals, Inc. Common Stock?
Collapse

Telomir Pharmaceuticals, Inc. Common Stock 200-day moving average is $2.15.

Who is Telomir Pharmaceuticals, Inc. Common Stock CEO?
Collapse

The CEO of Telomir Pharmaceuticals, Inc. Common Stock is Erez Aminov.

How many employees Telomir Pharmaceuticals, Inc. Common Stock has?
Collapse

Telomir Pharmaceuticals, Inc. Common Stock has 0 employees.

What is the market cap of Telomir Pharmaceuticals, Inc. Common Stock?
Collapse

The market cap of Telomir Pharmaceuticals, Inc. Common Stock is $45.4M.

What is the P/E of Telomir Pharmaceuticals, Inc. Common Stock?
Collapse

The current P/E of Telomir Pharmaceuticals, Inc. Common Stock is null.

What is the EPS of Telomir Pharmaceuticals, Inc. Common Stock?
Collapse

The EPS of Telomir Pharmaceuticals, Inc. Common Stock is -$0.37.

What is the PEG Ratio of Telomir Pharmaceuticals, Inc. Common Stock?
Collapse

The PEG Ratio of Telomir Pharmaceuticals, Inc. Common Stock is null.